Status:
COMPLETED
Pragmatic Trial of Messaging to Providers About Treatment of Heart Failure
Lead Sponsor:
Yale University
Collaborating Sponsors:
AstraZeneca
Conditions:
Heart Failure With Reduced Ejection Fraction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A randomized controlled trial to compare the efficacy of an electronic health record-based alert informing providers about evidence-based medications for HFrEF versus usual care (no alert) in outpatie...
Detailed Description
Data from clinical trials suggest that pharmacological therapies prescribed at appropriate doses will lead to dramatic improvements in survival and hospitalization rates in patients with heart failure...
Eligibility Criteria
Inclusion
- Patient
- Age 18 or over
- Seen in eligible internal medicine or cardiology clinic
- Left ventricular ejection fraction less than or equal to 40%
- Registered in the Yale Heart Failure Registry
- Patient
Exclusion
- Opted out of EHR-based research
- Under hospice care
- Already receiving each targeted class of evidence-based HFrEF medical therapy
- Selection of Providers:
- Practicing at an eligible internal medicine or cardiology clinic
- High frequency of visits by eligible patients based on retrospective chart review
Key Trial Info
Start Date :
January 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2022
Estimated Enrollment :
1410 Patients enrolled
Trial Details
Trial ID
NCT04514458
Start Date
January 25 2021
End Date
October 20 2022
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale New Haven Health System selected outpatient clinics
New Haven, Connecticut, United States, 06510